Thepreparation of thetitle compound was previously reported in [1] . Briefly, the synthetic route starts from reductive amination of (E)-4-chlorocinnamaldehyde with N-methyl-1-(2-nitrophenyl)-methanamine. The nitro group of the resulting (E)-3-(4-chlorophenyl)-N-methyl-N-(2-nitrobenzylprop-2-en-1-amine) is reduced with zinc and ammonium chloride to give the corresponding aniline, whichi si nt urnr eacted with 4-methoxybenzenesulfonylchloridetogiveKN-92.Finally,KN-92 is converted into KN-93 by alkylation of its sulfonamidic nitrogen with an hydroxyethyl group. Single crystals suitable for X-ray diffraction study were obtained by recrystallization from methanol at room temperature.
Source of material
Thepreparation of thetitle compound was previously reported in [1] . Briefly, the synthetic route starts from reductive amination of (E)-4-chlorocinnamaldehyde with N-methyl-1-(2-nitrophenyl)-methanamine. The nitro group of the resulting (E)-3-(4-chlorophenyl)-N-methyl-N-(2-nitrobenzylprop-2-en-1-amine) is reduced with zinc and ammonium chloride to give the corresponding aniline, whichi si nt urnr eacted with 4-methoxybenzenesulfonylchloridetogiveKN-92.Finally,KN-92 is converted into KN-93 by alkylation of its sulfonamidic nitrogen with an hydroxyethyl group. Single crystals suitable for X-ray diffraction study were obtained by recrystallization from methanol at room temperature.
Experimental details
Non-hydrogen atomsw ere refined anisotropically. Ha toms bound to C23 and C27 were constrained to the parent site and refined in the riding-model approximation with isotropic displacement parameters set at 1.5 U eq of the parent atom.All remaining H atoms were locatedf romad ifferenceF ourier mapa nd refined isotropically.
Discussion
Calmodulin-dependent protein kinase II (CaMKII) phosphorylates avariety of substrates. It is implicated in regulating many aspects of cellular function in response to Ca 2+ signalling, including the regulation of carbohydrate, amino acid and lipid metabolism,i on channel/receptors, neurotransmitter synthesis and release, transcription and translation, cytoskeletal organization andcalcium homeostasis [2, 3] . Moreover, CaMKII can modulate opioid tolerance via its action on learning and memory. Recently, it has been reported that sufficient inhibition of CaMKII is capable of reversing chronic inflammatory pain, and that CAMKII is involved in cardiac remodelling secondary to pathological stresses such as hypertension or myocardial infarction, as well as endothelial cell pathophysiology. Generally, the studies aboutC aMKIIa ctivitya re carriedo ut by usingas elective CaMKII inhibitor, KN-93, and its secondary amidic inactive analogue KN-92, which is used as anegative control and differs from KN-93 only for the absence of the hydroxyethyl substituent [4] . Looking for apossible explanation for the difference in activity of these two compounds, we studied the crystal structure of KN-93 dihydrogen phosphate methanol monosolvate. In the title crystal structure, the 2-propen-1-amine Nisprotonated and one phosphoric OH group is deprotonated. An intramolecular N1-H×××O1 hydrogen bond generating an S(9) ring is observed. The crystal structure exhibits as trong O-H×××Oh ydrogen bond between methanol and the dihydrogen phosphate anion. This is why the O9-H8 bond is longer than the usual OH bonds. Therefore H8 hydrogen is almost equally shared between O9 and O8. The cinnamyl residue is folded over the sulfonamide group. The crystal packing is stabilized by intermolecular p-p interactions between benzenesulfonamide moieties. As anticipated on the basiso fs ynthetic chemistryc onsiderations, spectroscopice vidences, and quantum chemical calculations [1] , the cinnamyl moiety presents E configuration. 
